Srirengam Muralidhasan MD LLC

Srirengam Muralidhasan MD LLC was paid $7.65M by Medicaid between Jan 2018 and Dec 2024, across 78 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 50% of everything it billed.

33Billing provider infoSRIRENGAM MURALIDHASAN MD LLC
LAS CRUCES, NM 88001

33aNPI1215929435assigned 08/16/2005

33bProvider typeFamily Medicine Physician

28Total paid$7.65M

24GClaims172,160

24DCodes billed78

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Family Medicine Physician providers in New Mexico

Rank by total paid#9 of 148

Median peer was paid$167K

This provider vs. median46×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	30,208	$931K
2019	28,630	$980K
2020	17,979	$806K
2021	24,868	$939K
2022	27,571	$1.38M
2023	23,564	$1.31M
2024incomplete	19,340	$1.30M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	50%	58,241	53,004	$3.83M
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	13%	9,383	9,335	$958K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	10%	9,182	8,740	$783K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	8.9%	6,910	6,814	$683K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	4.7%	9,454	9,254	$359K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	2.0%	9,214	9,085	$155K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	1.7%	1,277	1,258	$133K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	1.7%	7,975	7,639	$131K
99050		1.5%	13,495	13,082	$112K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	1.1%	2,110	2,091	$83K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	4,152	2,070	$67K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,838	1,832	$40K

66 more codes

90674		<1%	1,004	$29K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	245	$26K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	2,383	$21K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	125	$19K
71046	Radiologic examination, chest; 2 views	<1%	897	$18K
80053	Comprehensive metabolic panel	<1%	1,199	$14K
99051		<1%	426	$13K
36415	Collection of venous blood by venipuncture	<1%	4,441	$13K
81003		<1%	7,341	$12K
80050	General health panel	<1%	230	$12K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	222	$11K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	107	$11K
93000		<1%	815	$11K
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	<1%	545	$10K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	1,913	$10K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,037	$10K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	69	$8K
90688		<1%	591	$8K
80061	Lipid panel	<1%	379	$6K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	526	$5K
99204	Doctor's office visit, new patient (more involved)	<1%	24	$5K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	48	$5K
72100		<1%	146	$4K
90686		<1%	306	$4K
G0444	Annual depression screening, 5 to 15 minutes	<1%	351	$4K
90661		<1%	117	$4K
74019		<1%	121	$3K
73562		<1%	110	$3K
81025		<1%	304	$3K
92587		<1%	129	$3K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	2,413	$2K
99232	Hospital visit by a doctor, follow-up day	<1%	34	$2K
99223	Prolong inpt eval add15 m	<1%	12	$2K
84439		<1%	166	$2K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	2,785	$1K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	30	$1K
87807		<1%	56	$690.14
99238	Hospital discharge day management, 30 minutes or less	<1%	14	$646.20
73630		<1%	28	$591.48
73130		<1%	39	$573.30
90694		<1%	161	$536.31
94010		<1%	18	$532.35
98966		<1%	53	$528.17
90472	Immunization administration, each additional vaccine (list separately)	<1%	14	$521.11
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	14	$510.07
84443	Thyroid stimulating hormone (TSH)	<1%	24	$446.51
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	771	$433.09
99080		<1%	43	$388.76
94664		<1%	33	$388.76
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	14	$358.19
73030		<1%	14	$315.53
J2550	Injection, promethazine hcl, up to 50 mg	<1%	86	$188.29
90662		<1%	26	$177.81
G0008	Administration of influenza virus vaccine	<1%	325	$117.37
90653		<1%	19	$67.43
82962		<1%	15	$34.72
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	561	$27.82
36416		<1%	32	$2.25
90649		<1%	12	$0.09
G8427	Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications	0%	13	$0.00
G8752	Most recent systolic blood pressure < 140 mmhg	0%	66	$0.00
1160F		0%	32	$0.00
3078F		0%	13	$0.00
1125F		0%	2,382	$0.00
1126F		0%	2,373	$0.00
G8754	Most recent diastolic blood pressure < 90 mmhg	0%	87	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialQUINTANA, PATRICIA (OFFICE MANAGER)